A transient inflammatory reaction in the lung after experimental hemorrhagic shock and resuscitation with a hemoglobin-vesicles solution compared with rat RBC transfusion

ASAIO Journal

Volumn 55, Issue 5, 2009, Pages 478-483

  Yamanashi, Yoshitaka ^a   Mori, Masaki ^a   Terajima, Katsuyuki ^a   Tsueshita, Takaya ^a   Horinouchi, Hirohisa ^b   Sakai, Hiromi ^c   Sakamoto, Atsuhiro ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c WASEDA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL OXYGEN CARRIER; HEME OXYGENASE-1; HEMOGLOBIN VESICLES; HEMORRHAGIC SHOCK; HYPOXIA-INDUCIBLE FACTOR 1; INFLAMMATORY REACTION; INTERCELLULAR ADHESION MOLECULE-1; LUNG INJURY; MRNA LEVEL; NITRIC-OXIDE SYNTHASE; RAT MODEL; RECOMBINANT HUMAN SERUM ALBUMIN; RED BLOOD CELL; SECOND MESSENGER; TUMOR NECROSIS FACTOR ALPHA;

BIOLOGICAL ORGANS; BLOOD; ENZYMES; HEMOGLOBIN; NITRIC OXIDE; OXYGEN; OXYGENATION; PATHOLOGY; PORPHYRINS;

RESUSCITATION;

BLOOD SUBSTITUTE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEME OXYGENASE 1; HEMOGLOBIN; HEMOGLOBIN VESICLE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; RECOMBINANT HUMAN SERUM ALBUMIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; GENE EXPRESSION; HEMODYNAMICS; HEMORRHAGIC SHOCK; NONHUMAN; PNEUMONIA; RAT; RESUSCITATION; SECOND MESSENGER; TRANSFUSION INDUCED LUNG INJURY; TREATMENT OUTCOME;

ANIMALS; BLOOD COMPONENT TRANSFUSION; BLOOD SUBSTITUTES; ERYTHROCYTE TRANSFUSION; HEMODYNAMICS; HEMOGLOBINS; PNEUMONIA; RATS; RATS, SPRAGUE-DAWLEY; RESUSCITATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SHOCK, HEMORRHAGIC;

EID: 70349106414     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e3181b17f34     Document Type: Article

References (35)

1. Madjdpour C, Heindl V, Spahn DR: Risks, benefits, alternatives and indications of allogenic blood transfusions. Minerva Anestesiol 72: 283-298, 2006.
2. Winslow RM: Current status of oxygen carriers ('blood substitutes'). Vox Sang 91: 102-110, 2006.
3. Yoshizu A, Izumi Y, Park S, et al.: Hemorrhagic shock resuscitation with an artificial oxygen carrier, hemoglobin vesicle, maintains intestinal perfusion and suppresses the increase in plasma tumor necrosis factor-alpha. ASAIO J 50: 458-463, 2004.
4. Terajima K, Tsueshita T, Sakamoto A, Ogawa R: Fluid resuscitation with hemoglobin vesicle in a rabbit model of acute hemorrhagic shock. Shock 25: 184-189, 2006.
5. Goto Y, Terajima K, Tsueshita T, et al.: Fluid resuscitation with hemoglobin-vesicle solution does not increase hypoxia or inflammatory responses in moderate hemorrhagic shock. Biomed Res 27: 283-288, 2006.
6. Idriss HT, Naismith JH: TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc Res Tech 50: 184-195, 2000.
7. Biffl WL, Moore EE, Zallen G, et al.: Neutrophils are primed for cytotoxicity and resist apoptosis in injured patients at risk for multiple organ failure. Surgery 126: 198-202, 1999.
8. Botha AJ, Moore FA, Moore EE, et al.: Postinjury neutrophil priming and activation: An early vulnerable window. Surgery 118: 358-365, 1995.
9. Calkins CM, Hiemebach LK, Bensard DD, et al.: TNF receptor I mediates chemokine production and PMN accumulation in the lung following systemic lipopolysaccharide. J Surg Res 101: 232-237, 2001.
10. Satoh S, Nussler AK, Liu ZZ, Thomson AW: Proinflammatory cytokines and endotoxin stimulate ICAM-1 gene expression and secretion by normal human hepatocytes. Immunology 82: 571-576, 1994.
11. Koide M, Kawahara Y, Tsuda T, Yokoyama M: Cytokine-induced expression of an inducible type of nitric oxide synthase gene in cultured vascular smooth muscle cells. FEBS Lett 318: 213-217, 1994.
12. Kanno K, Hirata Y, Imai T, Marumo F: Induction of nitric oxide synthase gene by interleukin in vascular smooth muscle cells. Hypertension 22: 34-39, 1993.
13. Nowicki NJ, ShiD, Cai Z, Bishop PR, May WL: Developmental expression of endothelial nitoric oxide synthase (eNOS) in the rat liver. Pediatr Res 54: 732-738, 2003.
14. Wolzlaw C, Otto T, Berchner-Pfannschmidt U, et al.: Optical analysis of the HIF-1 complex in living cells by FRET and FRAP. FASEB J 21: 700-707, 2007.
15. Sakai H, Horinouchi H, Yamamoto M, et al.: Acute 40 percent exchange-transfusion with hemoglobin-vesicles (HbV) suspended in recombinant human serum albumin solution: degradation of HbV and erythropoiesis in a rat spleen for 2 weeks. Transfusion 46: 339-347, 2006.
16. Sasakawa S, Shiba M, Mura T, et al.: Development of addictive solution MAP for storage of red cell concentrates (in Japanese). Jpn J Transfus Med 37: 398-403, 1991.
17. Kobayashi K, Takemori K, Sakamoto A: Circadian gene expression is suppressed during sevoflurane anesthesia and the suppression persists after awakening. Brain Res 1185: 1-7, 2007.
18. Takemori K, Kobayashi K, Sakamoto A: Expression of pulmonary vasoactive factors after sevoflurane anesthesia in rats: a quantitative real-time polymerase chain reaction study. Br J Anaesth 100: 190-194, 2008.
19. Tinmouth A, Fergusson D, Yee IC, Hebert PC: Clinical consequences of red cell storage in the critically ill. Transfusion 46: 2014-2027, 2006. (Pubitemid 44631611)
20. Zallen G, Offner PJ, Moore EE, et al.: Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am J Sung 178: 570-572, 1999.
21. Hess JR, Macdonald VW, Brinkley WW: Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol 74: 1769-1778, 1993.
22. Sakai H, Masada Y, Tsuchida E, et al.: Hemoglobin-vesicles suspended in recombinant human serum albumin for resuscitation from hemorrhagic shock in anesthetized rats. Crit Care Med 32: 539-545, 2004.
23. Luk CS, Gray-Statchuk LA, Capinkas G, Chin-Yee IH: WBC reduction reduces storage-associated RBC adhesion to human vascular endothelial cells under conditions of continuous flow in vitro. Transfusion 43: 151-156, 2003.
24. Shibuya-Fujiwara N, Hirayama F, Ogata Y, et al.: Phagocytosis in vitro of polyethylene glycol-modified liposome-encapsulated hemoglobin by human peripheral blood monocytes plus macrophages through scavenger receptor. Life Sci 70: 291-300, 2001.
25. Shibuya-Fujiwara N, Hirayama F, Ogawa Y, et al.: Liposomeencapsulated augmentation of TNF-α production from peripheral blood leukocytes. Life Sci 69: 2007-2015, 2001.
26. Ertel W, Morrison MH, Ayala A, Chaudry IH: Chloroquine attenuates hemorrhagic shock-induced suppression of Kupffer cell antigen presentation and major histocompatibility complex class II antigen expression through blockade of tumor necrosis factor and prostaglandin release. Blood 78: 1781-1788, 1991.
27. Toda Y, Takahashi T, Maeshima K, et al.: A neutrophil elastase inhibitor, sivelestat, ameliorates lung injury after hemorrhagic shock in rats. Int J Mol Med 19: 237-243, 2007.
28. Maeshima K, Takahashi T, Uehara K, et al.: Prevention of hemorrhagic shock-induced lung injury by heme arginate treatment in rats. Biochem Pharmacol 69: 1667-1680, 2005.
29. Dayal SD, Hasko G, Lu Q, et al.: Trauma/hemorrhagic shock mesenteric lymph upregulates adhesion molecule expression and IL-6 production in human umbilical vein endothelial cells. Shock 17: 491-495, 2002.
30. Pittet JF, Lu LN, Morris DG, et al.: Reactive nitrogen species inhibit alveolar epithelial fluid transport after hemorrhagic shock in rats. J Immunol 166: 6301-6310, 2001.
31. Squadrito F, Altavilla D, Squadrito G, et al.: Recombinant human erythropoietin inhibits iNOS activity and revers vascular dysfunction in splanchnic artery occlusion shock. Br J Pharmacol 127: 482-488, 1999.
32. Abraham NG, Drummond GS, Lutton JD, Kappas A: The biological significance and physiological role of heme oxygenase. Cell Physiol Biochem 6: 129-168, 1996.
33. Tenhumen R, Marver HS, Schmid RJ: The enzymatic catabolism of hemoglobin: Stimulation of microsomal heme oxygenase by hemin. J Lab Clin Med 75: 410-421, 1970.
34. Tamion F, Richard V, Bonmarchand G, et al.: Induction of hemeoxigenase- 1 prevents the systemic responses to hemorrhagic shock. Am J Respir Crit Care Med 164: 1933-1938, 2001.
35. Welsh DJ, Scott PH, Peacock AJ: p38 MAP kinase isoform activity and cell cycle regulators in the proliferative response of pulmonary and systemic artery fibroblasts to acute hypoxia. Pulm Pharmacol Ther 19: 128-138, 2006.